TMCI is currently covered by 4 analysts with average potential upside of $8.22 (40.55%) backed by 0 price targets and 16 ratings. Documented since 18-May-2021. Analyst's average stock valuation to be materialised ratio is 29.43% with an average time for price targets to be met of 33.8 days.
Most recent stock forecast was given by DREW RANIERI from MORGAN STANLEY on 11-Oct-2022.
Highest price target for TMCI is 36, Lowest price target is 14, average price target is 25.
Currently, out of the existing stock ratings of TMCI - 14 which are a Buy (87.5%), 2 which are a Hold (12.5%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
28
$5.79 (26.07%)
23
5 months 14 days ago
4/7 (57.14%)
$5.27 (27.50%)
22
Buy
27
$2.25 (9.09%)
21
6 months 4 days ago
2/5 (40%)
$5.36 (25.63%)
27
Buy
28
$3.25 (13.13%)
22
6 months 4 days ago
1/2 (50%)
$6.73 (41.88%)
120
Buy
37
$12.25 (49.49%)
37
1 years 10 days ago
0/2 (0%)
$12.39 (59.06%)
Buy
32
$9.43 (41.78%)
38
1 years 4 months 13 days ago
0/5 (0%)
$11.36 (48.67%)
What is TMCI(Treace Medical Concepts Inc) average time for price targets to be met?
Which analyst has the current highest performing score on TMCI(Treace Medical Concepts Inc) with a proven track record?
